Knowledge, Attitudes and Practices Regarding Pregnancy Screening for Group B Streptococcus Among Women of Reproductive Age in Asir, southwestern Saudi Arabia: A Cross-Sectional Study
Implications for Public Health Policy and Maternal Healthcare Practice
DOI:
https://doi.org/10.52609/jmlph.v6i3.288Keywords:
Attitudes, Health Knowledge, Mass Screening, Practices, Pregnancy, Prenatal Care, Saudia Arabia, Sepsis, Streptococcus agalactiaeAbstract
Background: Group B Streptococcus (GBS) is a leading cause of early-onset neonatal sepsis, and antenatal screening with intrapartum antibiotic prophylaxis substantially reduces disease burden. Maternal awareness of, and participation in, GBS screening in Saudi Arabia remain poorly characterised.
Aim: To assess knowledge, attitudes, and practices (KAP) of women in the Asir Region, southwestern Saudi Arabia, regarding pregnancy screening for GBS, and to identify factors associated with higher knowledge, better practices, and more positive attitudes.
Methods: A cross-sectional study was conducted between June and November 2024 among women aged 18–45 years in the Asir Region. Data were collected using a validated, self-administered questionnaire assessing sociodemographic characteristics, pregnancy history, and GBS-related KAP. Composite scores were standardised to a 0–100 scale and dichotomised using the median. Multivariable logistic regression identified independent predictors.
Results: A total of 371 women participated (mean age 32.6 ± 9.3 years); 74.7% had heard of GBS. High knowledge, good practice, and positive attitude scores were observed in 49.1%, 35.8%, and 41.2% of participants, respectively. Previous pregnancy, prior history of GBS, and specialist obstetric care were independently associated with better practices and attitudes.
Conclusion: Despite relatively high awareness, GBS screening practices remain suboptimal, underscoring the need for standardised antenatal screening protocols and targeted education.
References
Morgan JA, Zafar N, Cooper DB. Group B streptococcus and pregnancy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jan 10]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482443/.
Mańdziuk J, Kuchar EP. Streptococcal meningitis. [Updated 2025 Jun 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554448/
Madrid L, Seale AC, Kohli-Lynch M, Edmond KM, Lawn JE, Heath PT, Madhi SA, Baker CJ, Bartlett L, Cutland C, Gravett MG, Ip M, Le Doare K, Rubens CE, Saha SK, Sobanjo-Ter Meulen A, Vekemans J, Schrag S; Infant GBS Disease Investigator Group. Infant group B streptococcal disease incidence and serotypes worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(Suppl 2):S160–72. doi:10.1093/cid/cix656.
Nanduri SA, Petit S, Smelser C, Apostal M, Alden NB, Harrison LH, Lynfield R, Vagnone PS, Burzlaff K, Spina NL, Dufort EM, Schaffner W, Thomas AR, Farley MM, Jain JH, Pondo T, McGee L, Beall BW, Schrag SJ. Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006–2015: multistate laboratory and population-based surveillance. JAMA Pediatr. 2019;173(3):224–33. doi:10.1001/jamapediatrics.2018.4826.
Russell NJ, Seale AC, O’Driscoll M, O’Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J, Lawn JE, Baker CJ, Bartlett L, Cutland C, Gravett MG, Heath PT, Le Doare K, Madhi SA, Rubens CE, Schrag S, Sobanjo-Ter Meulen A, Vekemans J, Saha SK, Ip M; GBS Maternal Colonization Investigator Group. Maternal colonization with group B streptococcus and serotype distribution worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(Suppl 2):S100–11. doi:10.1093/cid/cix658.
Musleh J, Al Qahtani N. Group B streptococcus colonization among Saudi women during labor. Saudi J Med Med Sci. 2018;6:18. doi:10.4103/sjmms.sjmms_175_16.
Mohamed AM, Khan MA, Faiz A, Ahmad J, Khidir EB, Basalamah MA, Aslam A. Group B streptococcus colonization, antibiotic susceptibility, and serotype distribution among Saudi pregnant women. Infect Chemother. 2020;52:70–81.
American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice. Prevention of group B streptococcal early-onset disease in newborns: ACOG Committee Opinion, Number 797. Obstet Gynecol. 2020;135(2):e51–72. doi:10.1097/AOG.0000000000003668.
Verani JR, McGee L, Schrag SJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1–36.
Berardi A, Spada C, Vaccina E, Boncompagni A, Bedetti L, Lucaccioni L. Intrapartum beta-lactam antibiotics for preventing group B streptococcal early-onset disease: can we abandon the concept of “inadequate” intrapartum antibiotic prophylaxis? Expert Rev Anti Infect Ther. 2020;18:37–46. doi:10.1080/14787210.2020.1697233.
Gopal Rao G, Nartey G, McAree T, O’Reilly A, Hiles S, Lee T, Wallace S, Batura R, Khanna P, Abbas H, Tilsed T, Nicholl R, Lamagni T, Bassett Pet al. Outcome of a screening programme for the prevention of neonatal invasive early-onset group B streptococcus infection in a UK maternity unit: an observational study. BMJ Open. 2017;7:e014634. doi:10.1136/bmjopen-2016-014634.
Khalil MR, Uldbjerg N, Thorsen PB, Møller JK. Risk-based approach versus culture-based screening for identification of group B streptococci among women in labor. Int J Gynaecol Obstet. 2019;144:187–91. doi:10.1002/ijgo.12721.
Puopolo KM, Lynfield R, Cummings JJ; American Academy of Pediatrics, Committee on Fetus and Newborn, Committee on Infectious Diseases. Management of infants at risk for group B streptococcal disease. Pediatrics. 2019;144(2):e20191881. doi:10.1542/peds.2019-1881.
General Authority for Statistics, Kingdom of Saudi Arabia. Population in Asir Region by gender, age group and nationality (Saudi/non-Saudi). Riyadh: GASTAT; [cited 2025 Jan 10]. Available from: https://www.stats.gov.sa/en/6140
Almalki M, Fitzgerald G, Clark M. Health care system in Saudi Arabia: an overview. East Mediterr Health J. 2011;17(10):784–93. doi:10.26719/2011.17.10.784.
Zoli SI, Baiti MA, Alhazmi AA, Khormi RM, Sayegh MA, Altubayqi T, Darisi AM, Alhasani RA, Alhazmi SH, Gharawi SO, Muhajir AA, Alhazmi AHet al. Factors affecting awareness of pregnancy screening for group B streptococcus infection among women of reproductive age in Jazan Province, Saudi Arabia. J Multidiscip Healthc. 2023;16:2109–16. doi:10.2147/JMDH.S421412.
Kelly MP, Barker M. Why is changing health-related behaviour so difficult? Public Health. 2016;136:109–16. doi:10.1016/j.puhe.2016.03.030.
Alamri Y, Albasri S, Abduljabbar GH, Alghamdi H, Balkhair AM, AlAam R. Awareness of pregnancy screening for group B streptococcus infection among women of reproductive age and physicians in Jeddah, Saudi Arabia. Cureus. 2021;13(10):e18765. doi:10.7759/cureus.18765.
Alshengeti A, Alharbi A, Alraddadi S, Alawfi A, Aljohani B. Knowledge, attitude and current practices of pregnant women towards group B streptococcus screening: a cross-sectional study, Al-Madinah, Saudi Arabia. BMJ Open. 2020;10:e032487. doi:10.1136/bmjopen-2019-032487.
Giles ML, Buttery J, Davey M-A, Wallace E. Pregnant women’s knowledge and attitude to maternal vaccination including group B streptococcus and respiratory syncytial virus vaccines. Vaccine. 2019;37:6743–9. doi:10.1016/j.vaccine.2019.08.084.
Clouse K, Shehabi A, Suleimat AM, Faouri S, Khuri-Bulos N, Al Jammal A, Chappell J, Fortner KB, Chamby AB, Randis TM, Ratner AJ, Aronoff DM, Halasa Net al. High prevalence of group B streptococcus colonization among pregnant women in Amman, Jordan. BMC Pregnancy Childbirth. 2019;19:177. doi:10.1186/s12884-019-2317-4.
AlZuheiri STS, Dube R, Menezes G, Qasem S. Clinical profile and outcome of group B streptococcal colonization in mothers and neonates in Ras Al Khaimah, United Arab Emirates: a prospective observational study. Saudi J Med Med Sci. 2021;9:235–40. doi:10.4103/sjmms.sjmms_213_21.
Abdelmaaboud M, Mohammed AF. Universal screening vs. risk-based strategy for prevention of early-onset neonatal group B streptococcal disease. J Trop Pediatr. 2011;57:444–50. doi:10.1093/tropej/fmr014.
Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, Harrison LH, Reingold A, Stefonek K, Smith G, Gamble M, Schuchat A; Active Bacterial Core Surveillance Team. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002;347(4):233–9. doi:10.1056/NEJMoa020205.
Hasperhoven GF, Al-Nasiry S, Bekker V, Villamor E, Kramer BWW. Universal screening versus risk-based protocols for antibiotic prophylaxis during childbirth to prevent early-onset group B streptococcal disease: a systematic review and meta-analysis. BJOG. 2020;127:680–91. doi:10.1111/1471-0528.16085.
Pangerl S, Sundin D, Geraghty S. Group B streptococcus screening guidelines in pregnancy: a critical review of compliance. Matern Child Health J. 2021;25:257–67. doi:10.1007/s10995-020-03113-z.
Rao GG, Khanna P. To screen or not to screen women for group B streptococcus (Streptococcus agalactiae) to prevent early-onset sepsis in newborns: recent advances in the unresolved debate. Ther Adv Infect Dis. 2020;7:2049936120942424. doi:10.1177/2049936120942424.
Angstetra D, Ferguson J, Giles WB. Institution of universal screening for group B streptococcus (GBS) from a risk management protocol results in reduction of early-onset GBS disease in a tertiary obstetric unit. Aust N Z J Obstet Gynaecol. 2007;47:378–82. doi:10.1111/j.1479-828X.2007.00760.x.
Stephens K, Charnock-Jones DS, Smith GCS. Group B streptococcus and the risk of perinatal morbidity and mortality following term labor. Am J Obstet Gynecol. 2023;228(Suppl 1):S1305–12. doi:10.1016/j.ajog.2022.07.051.
Gonçalves BP, Procter SR, Paul P, Chandna J, Lewin A, Seedat F, Koukounari A, Dangor Z, Leahy S, Santhanam S, John HB, Bramugy J, Bardají A, Abubakar A, Nasambu C, Libster R, Sánchez Yanotti C, Horváth-Puhó E, Sørensen HT, van de Beek D, Bijlsma MW, Gardner WM, Kassebaum N, Trotter C, Bassat Q, Madhi SA, Lambach P, Jit M, Lawn JE; GBS Danish and Dutch collaborative group for long term outcomes; GBS Low and Middle Income Countries collaborative group for long term outcomes; GBS Scientific Advisory Group, epidemiological sub-group; CHAMPS teamet al. Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden. Lancet Glob Health. 2022;10:e807–19. doi:10.1016/S2214-109X(22)00093-6.
Colbourn T, Asseburg C, Bojke L, Philips Z, Welton NJ, Claxton K, Ades AE, Gilbert REet al. Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses. BMJ. 2007;335(7621):655.
Le Doare K, O’Driscoll M, Turner K, Seedat F, Russel NJ, Seale AC, Heath PT, Lawn JE, Baker CJ, Bartlett L, Cutland C, Gravett MG, Ip M, Madhi SA, Rubens CE, Saha SK, Schrag S, Sobanjo-Ter Meulen A, Vekemans J, Kampmann B; GBS Intrapartum Antibiotic Investigator Group. Intrapartum antibiotic chemoprophylaxis policies for the prevention of group B streptococcal disease worldwide: systematic review. Clin Infect Dis. 2017;65(Suppl 2):S143–51. doi:10.1093/cid/cix654.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Yahya Shabi, Juman Hamzah Asiri, Asrar Gharsan Alqahtani, Raghad Yasser Azzawi, Shadan Ali Al Atif, Ghala Mohammed Asiri, Mada Hussain Al Jibril, Leen Omar Al Gelban, Saja Moraya Al Saleh, Albanadri Jamal Al Jathnan, Raghad Ibrahim Alzidani, Seham Saad Al Shahrani, Abdulaziz H. Alhazmi

This work is licensed under a Creative Commons Attribution 4.0 International License.
The Creative Commons Attribution 4.0 International License (CC BY 4.0) is a flexible and commonly used license that allows others to share, remix, adapt, and build upon the work even for commercial purposes, as long as they follow the requirements outlined by the license.